Showing 751-760 of 1317 results for "".
Long-term Management Strategies for AD, Melasma, and More
https://practicaldermatology.com/topics/psoriasis/long-term-management-strategies-for-ad-melasma-and-more/20801/After the acute treatment phase, experts urge a long-view on management.Habit Reversal Therapy for Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/habit-reversal-therapy-for-atopic-dermatitis/23951/Exploring CBT’s potential role for scratching frequency, itch intensity, and topical steroid utilization in atopic dermatitis.For Now, the No Surprises Act Applies to All Providers
https://practicaldermatology.com/topics/practice-management/for-now-the-no-surprises-act-applies-to-all-providers/23780/It seems that dermatologists and others providing aesthetic services must comply with new legislation.SDRIFE Induced by Liposomal Daunorubicin and Cytarabine
https://practicaldermatology.com/youngmd-connect/resident-resource-center/sdrife-induced-by-liposomal-daunorubicin-and-cytarabine/20830/The State of Private Equity in 2024: Impact on the Practice of Dermatology
https://practicaldermatology.com/columns/practice-management/state-private-equity-2024-impact-practice-dermatology/27173/Physician Growth Partners recently published a white paper, “State of Dermatology Private Equity,” that evaluated market trends, strategies, and more. Practical Dermatology® spoke exclusively with CEO Michael Kroin about how the evolution of private equity is impacting the everyday practitioner andHow Physicians Are Unlike Most US Investors
https://practicaldermatology.com/topics/practice-management/how-physicians-are-unlike-most-us-investors/23370/A look at how the difference in the tax situations of physicians and average retail investors, and why these differences matter.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?The Challenges of Topical Steroid Withdrawal
https://practicaldermatology.com/topics/practice-management/the-challenges-of-topical-steroid-withdrawalogy/21118/Now more widely reported, topical steroid addiction should compel all prescribers to reflect on their use of topical corticosteroids.New Advancements in Microneedle Resurfacing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-advancements-in-microneedle-resurfacing/21354/Microneedle resurfacing has quickly become one of the most in-demand aesthetic procedures, likely due to its strong results, quick healing times, and cost-effectiveness.